ARTICLE | Clinical News
Protegrin IB-367 aerosol: Began Phase I trial
January 25, 1999 8:00 AM UTC
IntraBiotics Pharmaceuticals Inc., Mountain View, Calif. Product: Protegrin IB-367 aerosol Business: Infectious diseases Therapeutic category: Bacterial infection, Membrane attack Target: Bacterial ce...